Home/Filings/4/0001593968-19-000567
4//SEC Filing

Marguglio David J. 4

Accession 0001593968-19-000567

CIK 0000887247other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 7:17 PM ET

Size

8.1 KB

Accession

0001593968-19-000567

Insider Transaction Report

Form 4
Period: 2019-02-21
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2019-02-2122,25844,515 total
    Common Stock (22,258 underlying)
  • Exercise/Conversion

    Common Stock

    2019-02-21+22,258401,013 total
Holdings
  • Common Stock

    (indirect: By Children)
    5,884
Footnotes (3)
  • [F1]Represents the vesting of a portion of previously granted restricted stock units (RSU), with shares of common stock to be issued following vesting of the RSUs as described in the award agreement relating to the RSUs.
  • [F2]Includes common stock, as well as restricted stock units granted on January 30, 2019, to the reporting person and previously reported on a Form 4.
  • [F3]On February 21, 2018, the reporting person was granted 66,773 restricted stock units. 1/3 of the Restricted Stock Units vest on each anniversary of the grant date over a three year period provided that the Reporting Person has continued to provide services to the Company during such period.

Issuer

Adamis Pharmaceuticals Corp

CIK 0000887247

Entity typeother

Related Parties

1
  • filerCIK 0001461753

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 7:17 PM ET
Size
8.1 KB